Preeclampsia could be treated with 'blood filtering' therapy, early study hints
A pilot study suggests that a blood-filtering therapy for preeclampsia is safe for both pregnant individuals and their fetuses. The treatment aims to reduce levels of a placental protein linked to the condition, which currently has no effective post-diagnosis intervention. Larger trials are needed to assess the therapy's effectiveness.
- ▪Preeclampsia affects up to 8% of pregnancies and can be life-threatening for both mother and baby.
- ▪The only current treatment for preeclampsia is delivery, which can lead to premature birth and associated health risks.
- ▪The new blood-filtering therapy targets a placental protein believed to play a role in the development of preeclampsia.
Opening excerpt (first ~120 words) tap to expand
Health Reproductive Health Preeclampsia could be treated with 'blood filtering' therapy, early study hints A blood-filtering therapy for preeclampsia is safe for pregnant patients and their babies, according to a new pilot study. By Lauren Schneider published 28 April 2026 in News When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Preeclampsia, a hypertensive condition that affects up to 8% of pregnancies, can be life-threatening for mothers and babies.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Live Science.
Discussion
0 commentsMore from Live Science
